Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy

Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma

(2011) Ricardo L. Favaretto et al.   BJU INTERNATIONAL

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Circulating Tumor Cells as Biomarkers in Prostate Cancer

(2011) D. C. Danila et al.   CLINICAL CANCER RESEARCH

Validation of Postoperative Nomograms in Prostate Cancer Patients with Long-term Follow-up

(2011) Gregory P. Swanson et al.   UROLOGY

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease

(2010) Axel Heidenreich et al.   EUROPEAN UROLOGY

Significant and Sustained Antitumor Activity in Post-Docetaxel, Castration-Resistant Prostate Cancer With the CYP17 Inhibitor Abiraterone Acetate

(2010) Alison H.M. Reid et al.   JOURNAL OF CLINICAL ONCOLOGY

Blood and Tissue Biomarkers in Prostate Cancer: State of the Art

(2010) Michelangelo Fiorentino et al.   UROLOGIC CLINICS OF NORTH AMERICA

A Simple and Accurate Model for Prediction of Cancer-Specific Mortality in Patients Treated with Surgery for Primary Penile Squamous Cell Carcinoma

(2009) L. Zini et al.   CLINICAL CANCER RESEARCH

Prognostic Significance of Circulating Tumor Cells in Patients With Hormone Refractory Prostate Cancer

(2009) Takatsugu Okegawa et al.   JOURNAL OF UROLOGY

An Update of the Gleason Grading System

(2009) Jonathan I. Epstein   JOURNAL OF UROLOGY

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

(2008) J. S. de Bono et al.   CLINICAL CANCER RESEARCH

Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer

(2008) G. Sardana et al.   CLINICAL CHEMISTRY

Clinicians are Most Familiar with Nomograms and Rate their Clinical Usefulness Highest, Look-up Tables are Second Best

(2008) Umberto Capitanio et al.   EUROPEAN UROLOGY

Quantification of PSA mRNA levels in peripheral blood of patients with localized prostate adenocarcinoma before, during, and after radical prostatectomy by quantitative real-time PCR (qRT-PCR)

(2008) Nadir Kalfazade et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Prognostic Significance of Disseminated Tumor Cells in the Bone Marrow of Prostate Cancer Patients Treated With Neoadjuvant Hormone Treatment

(2008) Jens Köllermann et al.   JOURNAL OF CLINICAL ONCOLOGY

External Validation of a Biomarker-Based Preoperative Nomogram Predicts Biochemical Recurrence After Radical Prostatectomy

(2008) Shahrokh F. Shariat et al.   JOURNAL OF CLINICAL ONCOLOGY

Immunomagnetic Quantification of Circulating Tumor Cells as a Prognostic Factor of Androgen Deprivation Responsiveness in Patients With Hormone Naive Metastatic Prostate Cancer

(2008) Takatsugu Okegawa et al.   JOURNAL OF UROLOGY

A Contemporary Study Correlating Prostate Needle Biopsy and Radical Prostatectomy Gleason Score

(2008) Samson W. Fine et al.   JOURNAL OF UROLOGY

Real-time quantitative RT-PCR assay of prostate-specific antigen and prostate-specific membrane antigen in peripheral blood for detection of prostate cancer micrometastasis

(2008) Liguo Zhang et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Prostate-Specific Antigen (PSA) as a Surrogate End Point for Survival in Prostate Cancer Clinical Trials

(2007) Laurence Collette   EUROPEAN UROLOGY